Physician profile
Jagan Devarajan
NPI 1578730594
$2,289.22
in general payments reported to CMS, 2019-2025
10 companies · $31.13 in 2025
The $31.13 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.75 · 2022: $52.90 · 2023: $1,944 · 2024: $225 · 2025: $31.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140 · Travel and Lodging: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.02 |
| Travel and Lodging | $1,059.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,554.00 | 2022-2024 | Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Vertos Medical, INC. | $184.78 | 2023-2024 | Mild Device Kit |
| Nevro Corp. | $145.04 | 2023 | Senza |
| Boston Scientific Corporation | $125.55 | 2023 | |
| Abbott Laboratories | $121.04 | 2023 | Proclaim |
| Averitas Pharma INC. | $43.04 | 2024 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $37.80 | 2024 | Exparel |
| Merck Sharp & Dohme LLC | $36.75 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $31.13 | 2025 | |
| Saluda Medical Americas, INC. | $10.09 | 2023 | Evoke Scs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagan Devarajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.